Evidence map›Paper›PMID 32986830›Full record

ArticleNucleic acids research2020

Elements at the 5' end of Xist harbor SPEN-independent transcriptional antiterminator activity.

Jackson B Trotman, David M Lee, Rachel E Cherney, Susan O Kim, Kaoru Inoue, Megan D Schertzer, Steven R Bischoff, Dale O Cowley, J Mauro Calabrese

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Xist in X chromosome inactivation: mechanisms and disease relevance.Cell communication and signaling : CCS · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Molecular and Nuclear Dynamics of X-Chromosome Inactivation.Cold Spring Harbor perspectives in biology · 2022
    Review
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jackson B TrotmanDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
David M LeeDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
Rachel E CherneyDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
Susan O KimDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
Kaoru InoueDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
Megan D SchertzerDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
Steven R BischoffAnimal Models Core, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Chapel Hill, NC 27599, USA.
Dale O CowleyAnimal Models Core, University of North Carolina at Chapel Hill, 120 Mason Farm Road, Chapel Hill, NC 27599, USA.
J Mauro CalabreseDepartment of Pharmacology and Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA.
UNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI David Darr · 1985 to 2026
$201.5M
NRSA IN GENETICST32GM007092 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEKELSKY, JEFF J. · 1985 to 2019
$5.9M
Mechanisms of gene silencing induced by long noncoding RNAsR01GM121806 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI CALABRESE, JOSEPH MAURO · 2017 to 2023
$2.3M
Cancer Epigenetics Training GrantT32CA217824 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEISSMAN, BERNARD E. · 2017 to 2021
$1.8M
NCI NIH HHS P30 CA016086NCI NIH HHS T32 CA217824NIGMS NIH HHS R01 GM121806NIGMS NIH HHS T32 GM007092
6 · The paper itself

Abstract

The Xist lncRNA requires Repeat A, a conserved RNA element located in its 5' end, to induce gene silencing during X-chromosome inactivation. Intriguingly, Repeat A is also required for production of Xist. While silencing by Repeat A requires the protein SPEN, how Repeat A promotes Xist production remains unclear. We report that in mouse embryonic stem cells, expression of a transgene comprising the first two kilobases of Xist (Xist-2kb) causes transcriptional readthrough of downstream polyadenylation sequences. Readthrough required Repeat A and the ∼750 nucleotides downstream, did not require SPEN, and was attenuated by splicing. Despite associating with SPEN and chromatin, Xist-2kb did not robustly silence transcription, whereas a 5.5-kb Xist transgene robustly silenced transcription and read through its polyadenylation sequence. Longer, spliced Xist transgenes also induced robust silencing yet terminated efficiently. Thus, in contexts examined here, Xist requires sequence elements beyond its first two kilobases to robustly silence transcription, and the 5' end of Xist harbors SPEN-independent transcriptional antiterminator activity that can repress proximal cleavage and polyadenylation. In endogenous contexts, this antiterminator activity may help produce full-length Xist RNA while rendering the Xist locus resistant to silencing by the same repressive complexes that the lncRNA recruits to other genes.

Indexed as

Transcription, GeneticAnimalsChromatinDNA-Binding ProteinsGene Expression Regulation, DevelopmentalGene SilencingMiceMouse Embryonic Stem CellsPolyadenylationRepetitive Sequences, Nucleic AcidRNA-Binding ProteinsRNA, Long NoncodingX ChromosomeX Chromosome InactivationChromatinDNA-Binding ProteinsRNA-Binding ProteinsRNA, Long NoncodingSpen protein, mouseXIST non-coding RNA

Identifiers

PMID32986830
PMCPMC7544216
OpenAlexW3090782836

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.